Cellply considers optimized patient stratification as the means for improving the standard of care in cancer therapeutics and, at the same time, reducing the economic burden currently faced by the healthcare system and industry.


Cellply aims at changing the way patient stratification is performed by introducing tools currently missing in the clinical setting to match the right drug with the right patient by means of personalized and individualized drug response profiles. With an approach consistently different from existing trends based on molecular and genomic patient profiling, Cellply mission is to complement such approaches to optimize patient-drug matching.